Coraza, Josefa L.
HRN: 04-39-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2023
CEFUROXIME 1.5GM (VIAL)
11/11/2023
11/18/2023
IV
1.5 G
Q8 H
CAP-MR; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes